Skip to main content
- Macrocystic LM: Macrocystic lymphatic malformation. LM with predominance of large cystic components. The distinction between macrocystic and microcystic LM is primarily of importance for responsiveness to sclerotherapy treatment and choice of therapeutic agent. There is no precise definition separating the two types, and many lesions are mixed.
- Microcystic LM: Microcystic lymphatic malformation. LM with predominance of small and multiple cystic components. The distinction between Macrocystic and microcystic LM is primarily of importance for responsiveness to sclerotherapy treatment and choice of therapeutic agent. There is no precise definition separating the two types, and many lesions are mixed.
- mTOR: Mammalian target of rapamycin. Intracellular target in the treatment of some vascular malformations, especially those caused by variants in the PI3Kinase pathway.
